The American Conservative by Rosemary Gibson 4/2/2020
If the coronavirus pandemic has taught us anything, the United States is unprepared for a disease outbreak or biowarfare because we no longer make the medicines necessary for survival.
Shortages of masks, ventilators, and respirators have made headline news but shortages of critical medicines have remained largely out of public view.
On February 27, 2020, the Food and Drug Administration (FDA) reported the shortage of a drug caused by the coronavirus outbreak in China. The agency didn’t name the drug because it would cause hoarding. Since then, the FDA has gone silent about shortages. Meanwhile, U.S. drug wholesalers are “allocating†critical generic drugs, an industry euphemism for rationing.
How dependent are we on China for medicines to care for people with severe cases of coronavirus? China is the source of 90 percent of the chemical starting materials needed to manufacture common generic drugs that help people recover. They include medicines to increase dangerously low blood pressure such as norepinephrine, the antibiotic azithromycin for bacterial infections, and propofol given when patients are placed on a ventilator to help them breathe.
More:
https://www.theamericanconservative.com/articles/chinas-cartels-those-who-control-the-medicines-control-the-world/
